Alejandra Carvajal
2023
In 2023, Alejandra Carvajal earned a total compensation of $1.6M as Senior Vice President, Chief Legal Officer at Mersana Therapeutics, a 84% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $120,557 |
|---|---|
| Option Awards | $780,966 |
| Salary | $430,560 |
| Stock Awards | $274,148 |
| Other | $7,000 |
| Total | $1,613,231 |
Carvajal received $781K in option awards, accounting for 48% of the total pay in 2023.
Carvajal also received $120.6K in non-equity incentive plan, $430.6K in salary, $274.1K in stock awards and $7K in other compensation.
Rankings
In 2023, Alejandra Carvajal's compensation ranked 727th out of 2,978 executives tracked by ExecPay. In other words, Carvajal earned more than 75.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 727 out of 2,978 | 76th |
Division Manufacturing | 416 out of 1,637 | 75th |
Major group Chemicals And Allied Products | 281 out of 906 | 69th |
Industry group Drugs | 275 out of 869 | 68th |
Industry Pharmaceutical Preparations | 181 out of 627 | 71st |
Source: SEC filing on April 26, 2024.
Carvajal's colleagues
We found six more compensation records of executives who worked with Alejandra Carvajal at Mersana Therapeutics in 2023.
2023
Anna Protopapas
Mersana Therapeutics
Chief Executive Officer
2023
Martin Huber
Mersana Therapeutics
Chief Executive Officer
2023
Arvin Yang
Mersana Therapeutics
Chief Medical Officer
2023
Brian DeSchuytner
Mersana Therapeutics
Chief Financial Officer
2023
Timothy Lowinger
Mersana Therapeutics
Senior Vice President, Chief Science and Technology Officer
2023
Mohan Bala
Mersana Therapeutics